Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Samuels

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Clinical Pharmacology|August 1, 1988
The correlation of vinblastine pharmacokinetics to toxicity in testicular cancer patientsC D Chong, C J Logothetis, N Savaraj, et al.
Cancer|January 1, 1977
Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteriaV J Lanzotti, D R Thomas, L E Boyle, et al.
Cancer Treatment Reviews|December 1, 1976
Combination chemotherapy in germinal cell tumorsM L Samuels, V J Lanzotti, P Y Holoye, et al.
Cancer|March 1, 1979
Management and results of localized Ewing's sarcomaR C Chan, W W Sutow, R D Lindberg, et al.
Cancer Treatment Reports|January 1, 1976
Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinomaV J Lanzotti, D R Thomas, P Y Holoye, et al.
Cancer|December 1, 1983
Superior vena cava obstruction in small cell bronchogenic carcinoma. Clinical parameters and survivalA M Maddox, M Valdivieso, J Lukeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1983
Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancerC J Logothetis, M L Samuels, A C von Eschenbach, et al.
The Journal of Urology|December 1, 1985
Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary reportC J Logothetis, M L Samuels, D E Selig, et al.
The Journal of Urology|September 1, 1985
Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastasesC J Logothetis, M L Samuels, S Ogden, et al.
Cancer Treatment Reports|July 1, 1982
Management of pelvic complications of malignant urothelial tumors with combined intra-arterial and iv chemotherapyC J Logothetis, M L Samuels, S Wallace, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pharmacology|August 1, 1988
The correlation of vinblastine pharmacokinetics to toxicity in testicular cancer patientsC D Chong, C J Logothetis, N Savaraj, et al.
Cancer|January 1, 1977
Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteriaV J Lanzotti, D R Thomas, L E Boyle, et al.
Cancer Treatment Reviews|December 1, 1976
Combination chemotherapy in germinal cell tumorsM L Samuels, V J Lanzotti, P Y Holoye, et al.
Cancer|March 1, 1979
Management and results of localized Ewing's sarcomaR C Chan, W W Sutow, R D Lindberg, et al.
Cancer Treatment Reports|January 1, 1976
Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinomaV J Lanzotti, D R Thomas, P Y Holoye, et al.
Cancer|December 1, 1983
Superior vena cava obstruction in small cell bronchogenic carcinoma. Clinical parameters and survivalA M Maddox, M Valdivieso, J Lukeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1983
Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancerC J Logothetis, M L Samuels, A C von Eschenbach, et al.
The Journal of Urology|December 1, 1985
Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary reportC J Logothetis, M L Samuels, D E Selig, et al.
The Journal of Urology|September 1, 1985
Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastasesC J Logothetis, M L Samuels, S Ogden, et al.
Cancer Treatment Reports|July 1, 1982
Management of pelvic complications of malignant urothelial tumors with combined intra-arterial and iv chemotherapyC J Logothetis, M L Samuels, S Wallace, et al.
Pageof 8